NCT06168149

Brief Summary

The aim of this study was to compare fetal lung elastography (FAE) values between groups with and without Respiratory Distress Syndrome (RDS) in preterm neonates and to evaluate the potential of FAE to predict the risk of developing RDS.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 6, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2024

Completed
Last Updated

March 17, 2026

Status Verified

March 1, 2026

Enrollment Period

8 months

First QC Date

November 17, 2023

Last Update Submit

March 16, 2026

Conditions

Keywords

Preterm LaborRespiratory Distress SyndromeFetal Lung ElastographyElastography

Outcome Measures

Primary Outcomes (1)

  • Fetal Lung Elastography Measurement

    Measurement of prenatal ultrasonographic shear wave elastographic values(kPa) of the fetus in cases of preterm labor

    Prenatal (24-34 gestational weeks, before 72 hours to delivery)

Study Arms (2)

Neonates with respiratory distress syndrome

A total of 80 patients with no systemic maternal disease findings and diagnoses, without chronic drug use, who were measured at least 24 hours after antenatal corticosteroids were administered during pregnancy, and whose delivery occurred within a maximum of 72 hours, will be included in our study as two case groups with and without RDS diagnosis in neonatal follow-up.

Diagnostic Test: fetal lung elastography measurement

Neonates who do not develop respiratory distress syndrome

A total of 80 patients with no systemic maternal disease findings and diagnoses, without chronic drug use, who were measured at least 24 hours after antenatal corticosteroids were administered during pregnancy, and whose delivery occurred within a maximum of 72 hours, will be included in our study as two case groups with and without RDS diagnosis in neonatal follow-up.

Diagnostic Test: fetal lung elastography measurement

Interventions

Elastography measurements are planned to be performed as in the studies "Feasibility of two-dimensional ultrasound shear wave elastography of human fetal lungs and liver: A pilot study" and "Feasibility of 2-D ultrasound shear wave elastography of fetal lungs in case of threatened preterm labour: a study protocol" in the literature examples section of the file.

Neonates who do not develop respiratory distress syndromeNeonates with respiratory distress syndrome

Eligibility Criteria

Age24 Weeks - 34 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study will include single pregnant women with maternal age of 18-45 years, gestational age between 24-34 weeks, diagnosed with preterm labor, amniotic fluid pathology, fetal congenital and chromosomal anomalies, and fetuses without fetal congenital and chromosomal anomalies, who were hospitalized in the ward after the application to the Perinatology Clinic of Etlik City Hospital. A total of 80 patients without systemic maternal disease findings and diagnoses, without chronic drug use, who were measured at least 24 hours after antenatal corticosteroids were administered and delivered within a maximum of 72 hours, will be included in our study as two case groups with and without RDS diagnosis in neonatal follow-up.

You may qualify if:

  • years old
  • Single pregnant women who were followed up with a diagnosis of preterm labor between 24-33 weeks and who volunteered and consented to the study
  • Measured at least 24 hours after antenatal corticosteroid and delivered within a maximum of 72 hours after measurement

You may not qualify if:

  • Multiple pregnancies
  • Amniotic fluid pathologies
  • Fetal lung and liver diseases
  • Fetal genetic and structural anomalies
  • Signs and diagnoses of systemic maternal diseases
  • Advanced maternal obesity preventing measurement
  • Patients hospitalized with a diagnosis of preterm labor and discharged before delivery
  • Presence of comorbid diseases of pregnancy (GDM, hypertensive diseases of pregnancy, PPROM, chorioamnionitis etc.)
  • Pregnant women over 45 years of age, systemic conditions (history of chronic, mental, physical illness, severe renal, hepatic, gastrointestinal acute/chronic inflammatory disease, hyperthyroidism, hypothyroidism, hypertension, type 1/2 DM, history of malignancy, smoking, alcohol use)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etlik City Hospital

Ankara, Yenimahalle, 06000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Obstetric Labor, PrematureRespiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesLung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Ahmet Kurt, 1

    Ankara Etlik City Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Physician- Obstetric and Gynecology Department

Study Record Dates

First Submitted

November 17, 2023

First Posted

December 13, 2023

Study Start

September 6, 2023

Primary Completion

May 15, 2024

Study Completion

September 6, 2024

Last Updated

March 17, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Patient data is not open to sharing due to hospital policy. however, if necessary, the principal investigator can be reached via e-mail.

Locations